Stay updated on Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor revision to the page's documentation/metadata.
    Difference
    0.1%
    Check dated 2026-07-05T04:57:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 is now shown in the page footer. This indicates a newer version of the page content.
    Difference
    0.1%
    Check dated 2026-06-28T01:33:48.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no ongoing participant enrollment. The page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, along with a revision note to v3.6.0 (replacing v3.5.5).
    Difference
    0.6%
    Check dated 2026-06-13T17:38:50.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.4 to v3.5.5, indicating a page rendering update that does not modify the clinical trial details or study data.
    Difference
    0.1%
    Check dated 2026-06-06T14:30:36.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new Revision label (v3.5.4) appears, replacing the previous v3.5.3. This reflects a minor product update to the page interface without altering study information.
    Difference
    0.1%
    Check dated 2026-05-16T09:32:47.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s revision label from v3.5.2 to v3.5.3, indicating a site/version refresh rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-25T05:27:42.000Z thumbnail image

Stay in the know with updates to Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.